EP1819227
Desítabínlyfjasamsetning.
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
8.12.2005EP published:
9.2.2011EP application number:
05853560.0
EP translation filed:
7.4.2011Grant published:
15.5.2011EPO information:
European Patent Register
Max expiry date:
7.12.2025Expiry date:
7.12.2025
Title:
PHARMACEUTICAL FORMULATION OF DECITABINE
Timeline
Owner
Name:
Astex Pharmaceuticals, Inc.Address:
4420 Rosewood Drive, Suite 200, 94588, Pleasanton, CA, US
Inventor
Name:
TANG, ChunlinAddress:
Walnut Creek, California, US
Name:
JOSHI-HANGAL, RajashreeAddress:
Pleasanton, California, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
9540Date:
10.12.2004Country:
US
Classification
Categories:
A61K 31/7068, A61K 31/724, A61K 47/48, A61P 3/00, A61P 9/10, A61P 35/00
Annual fees
Number
Paid
Expires
Payer
Number: 7
Paid: 22.11.2011
Expires: 7.12.2012
Payer: Sigurjónsson & Thor ehf.
Number: 8
Paid: 21.11.2012
Expires: 7.12.2013
Payer: Sigurjónsson & Thor ehf.
Number: 9
Paid: 19.11.2013
Expires: 7.12.2014
Payer: Sigurjónsson & Thor ehf.
Number: 10
Paid: 18.11.2014
Expires: 7.12.2015
Payer: Sigurjónsson & Thor ehf.
Number: 11
Paid: 18.11.2015
Expires: 7.12.2016
Payer: Sigurjónsson & Thor ehf.
Number: 12
Paid: 18.11.2016
Expires: 7.12.2017
Payer: Sigurjónsson & Thor ehf.
Number: 13
Paid: 20.11.2017
Expires: 7.12.2018
Payer: Sigurjónsson & Thor ehf.
Number: 14
Paid: 20.11.2018
Expires: 7.12.2019
Payer: Sigurjónsson & Thor ehf.
Number: 15
Paid: 19.11.2019
Expires: 7.12.2020
Payer: Sigurjónsson & Thor ehf.
Number: 16
Paid: 18.11.2020
Expires: 7.12.2021
Payer: Sigurjónsson & Thor ehf.
Number: 17
Paid: 8.11.2021
Expires: 7.12.2022
Payer: Árnason Faktor ehf.
Number: 18
Paid: 9.11.2022
Expires: 7.12.2023
Payer: Árnason Faktor ehf.
Number: 19
Paid: 15.11.2023
Expires: 7.12.2024
Payer: Árnason Faktor ehf.
Number: 20
Paid: 10.12.2024
Expires: 7.12.2025
Payer: G.H. Sigurgeirsson ehf.